T3	Subject 98 143	4 among approximately 2 000 Japanese patients
T4	Treatment 157 166	sorafenib
T5	Effect 63 85	interstitial pneumonia
T8	Race 126 134	Japanese
T7	Population 98 125	4 among approximately 2 000
T9	Drug 157 166	sorafenib
T6	Adverse_event 86 94	occurred
E1	Adverse_event:T6